Clinical Trials Logo

Clinical Trial Summary

The objective of this clinical study is to demonstrate efficacy and feasibility of a long-term dietary intervention to modify intestinal inflammation in high-risk patient cohorts. To this end a 78 weeks wheat protein-free diet will be administered in patients with inflammatory bowel disease (IBD) with and without associated primary sclerosing cholangitis (PSC-IBD).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Inflammation
  • Reduction of Intestinal Inflammatory Activity

NCT number NCT05867537
Study type Interventional
Source Universitätsklinikum Hamburg-Eppendorf
Contact
Status Recruiting
Phase N/A
Start date January 18, 2023
Completion date January 2028

See also
  Status Clinical Trial Phase
Completed NCT04006886 - Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) N/A